UBS Group’s Immunomedics Inc IMMU Stock Holding History

UBS Group’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-21,600	Closed	-$1.84M	–	9155
2020 Q3	$1.84M	Buy	+21,600	New	+$1.09M	﹤0.01%	3126
2019 Q3	–	Sell	-50,000	Closed	-$694K	–	8449
2019 Q2	$694K	Buy	+50,000	New	+$752K	﹤0.01%	4040
2016 Q1	–	Sell	-43,900	Closed	-$135K	–	8439
2015 Q4	$135K	Hold	43,900	–	–	﹤0.01%	4987
2015 Q3	$76K	Hold	43,900	–	–	﹤0.01%	5466
2015 Q2	$178K	Hold	43,900	–	–	﹤0.01%	4967
2015 Q1	$168K	Sell	43,900 -16,600	-27%	-$72.2K	﹤0.01%	5014
2014 Q4	$290K	Buy	+60,500	New	+$239K	﹤0.01%	4685

UBS Group's IMMU Position: Q4 2020 in Review

UBS Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 291,642 shares — an estimated $24.8M sold.

UBS Group first reported a position in IMMU in Q4 2014 and held it in 24 quarters. The position peaked at $24.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

UBS Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
UBS Group sold 291,642 Immunomedics Inc shares in Q4 2020, an estimated $24.8M.
UBS Group first reported a position in Immunomedics Inc in Q4 2014 and held it in 24 quarters.
UBS Group's Immunomedics Inc position peaked at $24.8M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.